GLP-1 Y U Ozempic Broke?

GLP-1 Y U Ozempic Broke?

6 bookmarks
Custom sorting
Glucagon-Like Peptide-1 Receptor Agonists - StatPearls - NCBI Bookshelf
Glucagon-Like Peptide-1 Receptor Agonists - StatPearls - NCBI Bookshelf
Glucagon-like peptide-1 (GLP-1) agonists are a class of medications utilized to treat type 2 diabetes mellitus (T2DM) and obesity. As a class of medications, they are among several pharmacological options for these endocrine diseases. The function of GLP-1 agonists is to lower serum glucose levels and thereby manage metabolism in affected patients. Participating clinicians gain an enhanced understanding of when to prescribe these agonists, consider specific patient populations, and seek consultations with specialists in the care of their patients. Recent recommendations regarding mixed formulations are also included in alignment with current research on this drug class. This activity will highlight the indications, mechanism of action, administration, adverse effect profile, and contraindications for these drugs. An interprofessional team of nurses, primary care clinicians, pharmacists, and endocrinologists remains pertinent to care for patients prescribed this class of medications.
·ncbi.nlm.nih.gov·
Glucagon-Like Peptide-1 Receptor Agonists - StatPearls - NCBI Bookshelf
Overview of incretin hormones - PubMed
Overview of incretin hormones - PubMed
Incretins are hormones released by nutrients from the GI tract. They amplify glucose-induced insulin release. By raising circulating incretin levels, oral glucose provokes a higher insulin response than that resulting from intravenous glucose. The two most important incretin hormones are glucose-dep …
·pubmed.ncbi.nlm.nih.gov·
Overview of incretin hormones - PubMed